Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: September 2009
-
By Suresh Pillai — Purdue Files Appeal in Ultram® Suit against Par Purdue Pharma Products Inc. has filed an appeal with the U.S. Court of Appeals for the Federal Circuit seeking to overturn an earlier federal court decision that invalidated Purdue's patents (U.S. Patent Nos. 7,074,430 and 6,254,887 covering their product, Ultram ER®. Purdue…
-
By Donald Zuhn — Last month, ChemBridge Corp. announced that it would make ten of its most popular chemical screening libraries available to researchers via the Collaborative Drug Discovery (CDD) Public Access database. The CDD Public Access database, a collection of public data from leading vendors, researchers, scientific literature, and patent resources, is hosted by…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Warner Chilcott C. LLC v. Lupin Limited et al.1:09-cv-00673; filed September 9, 2009 in the District Court of Delaware • Plaintiff: Warner…
-
September 13-15, 2009 – 2009 Annual Meeting (Intellectual Property Owners Association) – Chicago, IL September 14-15, 2009 – 3rd Summit on Biosimilars and Follow-on Biologics*** (Center for Business Intelligence) – National Harbor, MD September 15-16, 2009 – FDA Boot Camp*** (American Conference Institute) – Boston, MA September 17, 2009 – Developments in Pharmaceutical and Biotech…
-
By Donald Zuhn — Last week, Dr. Simos Simeonidis, a Senior Biotechnology Analyst for Rodman & Renshaw, LLC, provided FierceBiotech with a list of five biotech companies to watch in the coming months ("Five Biotech Companies to Watch"). On Dr. Simeonidis' list were Poniard Pharmaceuticals, GTx, OncoGenex, MannKind Corp., and Rigel Pharmaceuticals. Dr. Simeonidis…
-
The World Intellectual Property Organization (WIPO) will hold a one-day seminar on the Patent Cooperation Treaty (PCT) for small and medium-sized enterprises and independent inventors on November 10, 2009 in Baltimore, MD and on November 13, 2009 in Las Vegas, NV. During each session, WIPO staff will provide an overview of the PCT, outline its…
-
More Claim Construction Confusion from the Federal Circuit By Kevin E. Noonan — The Federal Circuit demonstrated once again the quagmire that can exist when lower courts attempt to apply the CAFC's rather quixotic jurisprudence on claim construction. The case, Sanofi-Aventis U.S. LLC v. Sandoz, Inc.(1), arose as the result of ANDA filings by…
-
By Kevin E. Noonan — The Biotechnology Industry Organization (BIO) held a media briefing on Federal policy issues today, with most of BIO's executive staff assembling at BIO headquarters in Washington, D.C. In addition to the media present on site, BIO hosted several more members of the press by teleconference. Jim Greenwood (at left),…
-
By Donald Zuhn — Last month, OncoGenex Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office had issued U.S. Patent No. 7,569,551. The '551 patent is directed to a method of enhancing cancer cell chemo- or radiation-sensitivity using an antisense oligodeoxynucleotide targeted against the testosterone-repressed prostate message-2 (TRPM-2) gene. The inventors found that…
-
By Christopher P. Singer — In a press release issued last week, the U.S. Patent and Trademark Office announced that current Commissioner for Patents, John Doll, has indicated that he plans to retire from the agency on October 2, 2009. USPTO Director David Kappos has nominated Robert Stoll (at right), a current USPTO executive,…
Patent Docs 